Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Krystal Biotech Inc

KRYS
177,78
-4,94 (-2,70%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/6/202400:09PRNUSKKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500;..
05/6/202413:00GLOBEKrystal Biotech to Present at Goldman Sachs 45th Annual..
21/5/202422:38EDGAR2Form 8-K - Current report
15/5/202413:00GLOBEKrystal Biotech to Present at the American Thoracic Society..
08/5/202413:00GLOBEKrystal Biotech to Present at BofA Securities 2024 Health..
06/5/202414:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202414:09IHMARKETNEWSIndex Futures Point to Strong Monday Opening, Building on..
06/5/202414:04EDGAR2Form 8-K - Current report
06/5/202414:00GLOBEKrystal Biotech Announces First Quarter 2024 Financial..
02/5/202413:00GLOBEKrystal Biotech to Present at the Association for Research..
26/4/202413:00GLOBEKrystal Biotech to Report First Quarter 2024 Financial..
22/4/202413:00GLOBEKrystal Biotech Announces First Patient Dosed in Phase 1..
04/4/202413:00GLOBEKrystal Biotech to Present at the American Association..
02/3/202402:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/3/202402:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202403:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:00GLOBEKrystal Biotech to Present at TD Cowen 44th Annual Health..
26/2/202419:35EDGAR2Form 144 - Report of proposed sale of securities
26/2/202414:04EDGAR2Form 8-K - Current report
26/2/202414:00GLOBEKrystal Biotech Announces Fourth Quarter and Full Year 2023..
26/2/202413:59EDGAR2Form S-8 - Securities to be offered to employees in employee..
26/2/202413:49EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202411:57IHMARKETNEWSU.S. Index Futures Dip Amid Inflation Data Anticipation, Oil..
20/2/202413:00GLOBEKrystal Biotech to Report Fourth Quarter and Full Year 2023 ..
13/2/202413:00GLOBEKrystal Biotech Receives FDA Fast Track Designation for..
08/2/202413:00GLOBEKrystal Biotech Announces Publication in the New England..
01/2/202413:00GLOBEKrystal Biotech to Present at Guggenheim 6th Annual..
24/1/202423:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/1/202417:43EDGAR2Form 144 - Report of proposed sale of securities
04/1/202413:00GLOBEKrystal Biotech Receives Permanent J-code (J3401) for..
19/12/202313:00GLOBEKrystal Biotech Receives Orphan Drug Designation from the..
27/11/202313:00GLOBEKrystal Biotech Announces EMA Validation of Marketing..
09/11/202313:00GLOBEKrystal Biotech to Present at the Stifel 2023 Healthcare..
06/11/202313:10EDGAR2Form 8-K - Current report
06/11/202313:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202313:00GLOBEKrystal Biotech Announces Third Quarter 2023 Financial..
30/10/202312:00GLOBEKrystal Biotech to Report Third Quarter 2023 Financial..
02/10/202318:07EDGAR2Form 144 - Report of proposed sale of securities
28/9/202313:00GLOBEKrystal Biotech to Present at the Chardan 7th Annual Genetic..
07/9/202313:00GLOBEKrystal Biotech to Present at the Morgan Stanley 21st Annual..
05/9/202313:00GLOBEKrystal Biotech Announces Orphan Drug Designation Granted to..
21/8/202323:30EDGAR2Form 144 - Report of proposed sale of securities
16/8/202322:57EDGAR2Form 144 - Report of proposed sale of securities
15/8/202322:56EDGAR2Form 144 - Report of proposed sale of securities
11/8/202322:39EDGAR2Form 144 - Report of proposed sale of securities
11/8/202300:06EDGAR2Form 144 - Report of proposed sale of securities
07/8/202314:18EDGAR2Form 8-K - Current report
07/8/202313:13EDGAR2Form 8-K - Current report
07/8/202313:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202313:00GLOBEKrystal Biotech Announces Second Quarter 2023 Financial..
Apertura: 180,21 Min: 174,29 Max: 181,25
Chiusura: 182,72

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network